Teleflex Incorporated (NYSE:TFX) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC reduced its position in Teleflex Incorporated (NYSE:TFX) by 59.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,224 shares of the medical technology company’s stock after selling 4,802 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Teleflex were worth $574,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Simplify Asset Management Inc. acquired a new stake in shares of Teleflex in the third quarter valued at approximately $4,800,000. JPMorgan Chase & Co. boosted its holdings in shares of Teleflex by 14.3% in the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock valued at $38,374,000 after acquiring an additional 19,466 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its holdings in shares of Teleflex by 5.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock valued at $19,263,000 after acquiring an additional 5,322 shares during the period. Lecap Asset Management Ltd. acquired a new stake in shares of Teleflex in the fourth quarter valued at approximately $729,000. Finally, Mirae Asset Global Investments Co. Ltd. boosted its holdings in shares of Teleflex by 35.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock valued at $1,053,000 after acquiring an additional 1,527 shares during the period. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on TFX. Truist Financial decreased their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a report on Monday, December 16th. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Mizuho decreased their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Finally, Royal Bank of Canada decreased their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Trading Up 1.1 %

Shares of TFX stock opened at $169.33 on Wednesday. Teleflex Incorporated has a fifty-two week low of $165.62 and a fifty-two week high of $253.06. The stock has a market cap of $7.86 billion, a P/E ratio of 33.66, a P/E/G ratio of 1.65 and a beta of 1.16. The business has a fifty day simple moving average of $177.75 and a 200-day simple moving average of $208.74. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.